Merck cleared in personal injury case against VioxxBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7525.1101-a (Published 10 November 2005) Cite this as: BMJ 2005;331:1101
- Susan Mayor
The pharmaceutical company Merck has won a personal injury court case associated with its cyclo-oxygenase-2 inhibitor rofecoxib (Vioxx) in the United States, a jury ruled in Atlantic City last week. This is the second case to be brought against the drug giant out of more than 6000 claims expected from people or their relatives who say they were harmed by rofecoxib. Merck lost the first case.
In the most recent case, the state court jury found by an eight to one vote that Vioxx had not caused Frederick Humeston, a 60 year old Idaho postal worker, to have a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial